About this tool
This tool applies the Rule of 7s to a child with CSF pleocytosis in a Lyme-endemic area, to separate Lyme meningitis from viral (aseptic) meningitis while Lyme serology is pending. It is used once bacterial meningitis is judged unlikely.
Answer whether bacterial meningitis is still possible, whether there is erythema migrans, and the three features: headache for 7 days or more, CSF mononuclear cells 70% or more, and any cranial nerve palsy (usually the facial nerve). A child with none of the three is low risk.
The result gives low risk (consider care at home without antibiotics while serology is pending, with clear return advice) or not low risk (send serology and consider treating for Lyme meningitis while waiting), with the performance from the validation studies: sensitivity 96–98%, specificity about 40%, 2% Lyme meningitis among low-risk children without erythema migrans. Treatment options follow IDSA/AAN/ACR 2020; doses are in the Lyme disease tool. Sources: Garro et al. (Pediatrics 2009), Cohn et al. (Pediatrics 2012), Garro et al. (Pediatr Infect Dis J 2021).
Common questions
What is the Rule of 7s for Lyme meningitis?
A child with CSF pleocytosis is at low risk of Lyme meningitis when all three are true: headache for less than 7 days, less than 70% mononuclear cells in the CSF, and no cranial nerve palsy (most often the 7th, facial nerve).
How accurate is the Rule of 7s?
In pooled data from 4 cohorts (721 children) sensitivity was 98%, specificity 40% and negative predictive value 100% (95% CI 95–100%). In a 423-child validation, 3 of 127 low-risk children without erythema migrans had Lyme meningitis (2%).
Can a low-risk child go home before Lyme serology returns?
The validation studies suggest low-risk children can be managed as outpatients while awaiting serology, if bacterial meningitis is unlikely, the child looks well and follow-up is assured. Treat if the serology is positive.
How is Lyme meningitis treated in children?
IDSA/AAN/ACR 2020 recommends oral doxycycline or IV ceftriaxone (or cefotaxime or penicillin G) for 14–21 days. Weight-based doses are in the Pedemy Lyme disease tool.